SynthesisJournal of oral rehabilitation2026
Is Capsaicin Effective in Relieving the Symptoms of Burning Mouth Syndrome? A Systematic Review.
Synthesis in Journal of oral rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBurning Mouth Syndrome (BMS) is a type of chronic orofacial pain characterised by a burning sensation inside the mouth without an apparent cause. Capsaicin has been used to manage the symptoms of this syndrome, but there is still no consensus on its effectiveness.
objectiveTo assess whether capsaicin, when used topically or systemically, is able to alleviate the symptoms of BMS.
methodsAn extensive search was carried out in seven databases and grey literature up to November 2025. There were no restrictions regarding the date or language of publication.
resultsThe search resulted in 782 articles, of which 4 were included. The methodological quality of the studies was assessed using the Risk of Bias in Systematic Reviews (ROBIS) tool and the certainty of evidence was performed according to Grading of Recommendations, Assessment, Development and Evaluation (GRADE). Regarding capsaicin administration, 3 studies used topical application and 1 used systemic application. Concentrations ranged from 0.000354% to 0.25%, three times a day, for 1-8 weeks. Regardless of the administration method, a reduction in patient-reported pain scores was observed. Risk of bias assessment showed that three randomised studies presented a moderate risk, while the only non-randomised clinical trial presented a critical risk. The overall certainty of the evidence was low or very low for the outcomes assessed.
conclusionEvidence suggests that capsaicin is effective in relieving BMS symptoms. However, this result should be interpreted with caution due to the low quality of the evidence obtained to support its use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.